Association of serum androgen concentrations with cardiovascular risk factors in elderly male patients with chronic systolic heart failure in China

Aging Male

Volumn 17, Issue 3, 2014, Pages 155-160

  Chen, Qian ^a   Fu, Zhiqing ^a   Wu, Xueping ^a   Jin, Lan ^a   Li, Jiangyuan ^a   Wang, Yutang ^a   Li, Xiaoying ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Androgen; Cardiovascular risk factors; Elderly; Heart failure; Male

Indexed keywords

ANDROGEN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PRASTERONE SULFATE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; TRIACYLGLYCEROL;

ADULT; AGED; AGING; ANDROGEN BLOOD LEVEL; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CHINA; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SMOKING; SYSTOLIC BLOOD PRESSURE; SYSTOLIC HEART FAILURE; BLOOD; CARDIOVASCULAR DISEASES; CASE CONTROL STUDY; CHRONIC DISEASE; EPIDEMIOLOGY; HEART FAILURE, SYSTOLIC; MIDDLE AGED; RISK FACTOR; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANDROGENS; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; CHINA; CHRONIC DISEASE; DEHYDROEPIANDROSTERONE SULFATE; HEART FAILURE, SYSTOLIC; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; SEX HORMONE-BINDING GLOBULIN; TESTOSTERONE;

EID: 84906352901     PISSN: 13685538     EISSN: 14730790     Source Type: Journal    
DOI: 10.3109/13685538.2014.896893     Document Type: Article

References (39)

1. Ammar KA, Jacobsen SJ, Mahoney DW, et al. Prevalence and prognostic significance of heart failure stages: Application of the American College of Cardiology/American Heart Association heart failure staging criteria in the community. Circulation 2007;115: 1563-70
2. Malkin CJ, Jones TH, Channer KS. Testosterone in chronic heart failure. Front Horm Res 2009;37:183-96
3. Traish AM, Saad F, Feeley RJ, Guay A. The dark side of testosterone deficiency: Cardiovascular disease. J Androl 2009;30: 477-94
4. Li JY, Li XY, Li M, et al. Decline of serum levels of free testosterone in aging healthy Chinese men. Aging Male 2005;8: 203-6
5. Jankowska EA, Biel B, Majda J, et al. Anabolic deficiency in men with chronic heart failure prevalence and detrimental impact on survival. Circulation 2006; 14:1829-37
6. Mustafa T, Finlay AM, Erin EC, et al. Testosterone supplementation in heart failure: A meta-Analysis. Circ Heart Fail 2012;5: 315-21
7. Pugh PJ, Jones RD, Jones TH, Channer KS. Heart failure as an inflammatory condition: Potential role for androgens as immune modulators. Eur J Heart Fail 2002;4:673-80
8. Maggio M, Lauretani F, Ceda GP, et al. Relationship between low levels of anabolic hormones and 6-year mortality in older men: The aging in the Chianti Area (InCHIANTI) study. Arch Intern Med 2007;167:2249-54
9. Firtser S, Juonala M, Magnussen CG, et al. Relation of total and free testosterone and sex hormone-binding globulin with cardiovascular risk factors in men aged 24-45 years. The Cardiovascular Risk in Young Finns Study. Atherosclerosis 2012;222:257-62
10. Mäkinen JI, Perheentupa A, Irjala K, et al. Endogenous testosterone and serum lipids in middle-Aged men. Atherosclerosis 2008;197: 688-93
11. Shahani S, Braga-Basaria M, Basaria S. Androgen deprivation therapy in prostate cancer and metabolic risk for atherosclerosis. J Clin Endocrinol Metab 2008;93:2042-9
12. Alexandersen P, Haarbo J, Christiansen C. The relationship of natural androgens to coronary heart disease in males: A review. Atherosclerosis 1996;125:1-13
13. Wehr E, Pilz S, Boehm BO, et al. Low free testosterone is associated with heart failure mortality in older men referred for coronary angiography. Eur J Heart Fail 2011;13:482-8
14. Chen Q, Li XY, Li JY, et al. A comparative survey of sex hormones levels between elderly men with chronic heart failure and normal elderly subjects. Zhonghua Xin Xue Guan Bing Za Zhi 2005;33: 505-8
15. Caminiti G, Volterrani M, Iellamo F, et al. Effect of long-Acting testosterone treatment on functional exercise capacity, skeletal muscle performance, insulin resistance, and baroreflex sensitivity in elderly patients with chronic heart failure: A double-blind, placebo-controlled, randomized study. J Am Coll Cardiol 2009;54: 919-27
16. Mizuno Y, Yoshimura M, Yasue H, et al. Aldosterone production is activated in the failing ventricles in humans. Circulation 2001;103: 72-7
17. Nakamura S, Yoshimura M, Nakayama M, et al. Possible association of heart failure status with synthetic balance between aldosterone and dehydroepiandrosterone in human heart. Circulation 2004;110:1787-93
18. Bhasin S, Cunningham GR, Hayes FJ, et al. Testosterone therapy in men with androgen deficiency syndromes: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2010;95: 2536-59
19. Bhasin S, Pencina M, Jasuja GK, et al. Reference ranges for testosterone in men generated using liquid chromatography tandem mass spectrometry in a community-based sample of healthy nonobese young men in the Framingham Heart Study and applied to three geographically distinct cohorts. J Clin Endocrinol Metab 2011;96:2430-9
20. Yeap BB, Alfonso H, Chubb SAP, et al. Reference ranges and determinants of testosterone, dihydrotestosterone, and estradiol levels measured using liquid chromatography-tandem mass spectrometry in a population-based cohort of older men. J Clin Endocrinol Metab 2012;97:4030-9
21. Liu PY, Death AK, Handelsma DJ. Androgens and cardiovascular disease. Endocr Rev 2003;24:313-40
22. Zitzmann M. Testosterone deficiency, insulin resistance and the metabolic syndrome. Nat Rev Endocrinol 2009;5:673-81
23. Page ST, Amory JK, Bowman FD, et al. Exogenous testosterone (T) alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum T. J Clin Endocrinol Metab 2005;90:1502-10
24. Bernini G, Versari D, Moretti A, et al. Vascular reactivity in congenital hypogonadal men before and after testosterone replacement therapy. J Clin Endocrinol Metab 2006;91:1691-7
25. Isidori, AM, Giannetta E, Pozza C, et al. Androgens, cardiovascular disease and osteoporosis. J Endocrinol Invest 2005;28:73-9
26. Traish AM, Haider A, Doros G, Saad F. Long-term testosterone therapy in hypogonadal men ameliorates elements of the metabolic syndrome: An observational, long-term registry study. Int J Clin Pract 2013. doi: 10.1111/ijcp.12319. [Epub ahead of print].
27. Traish AM, Abdoua R, Kypreos KE. Androgen deficiency and atherosclerosis: The lipid link. Vascul Pharmacol 2009;51:303-13
28. Svartberg J, von Muhlen D, Schirmer H, et al. Association of endogenous testosterone with blood pressure and left ventricular mass in men. The Tromsø Study. Eur J Endocrinol 2004;150: 65-71
29. Güder G, Frantz S, Bauersachs J, et al. Low circulating androgens and mortality risk in heart failure. Heart 2010;96:504-9
30. Kapoor D, Malkin CJ, Channer KS, Jones TH. Androgens, insulin resistance and vascular disease in men. Clin Endocrinol 2005;63: 239-50
31. Maurizio V, Giuseppe R, Ferdinando I. Testosterone and heart failure. Endocrine 2012;42:272-7
32. Zietz B, Schäffler A, Büttner R, et al. Elevated levels of leptin and insulin but not of TNF alpha are associated with hypertension in type 2 diabetic males. Exp Clin Endocrinol Diab 2000;108:259-64
33. Li C, Ford ES, Li B, et al. Association of testosterone and sex hormone-binding globulin with metabolic syndrome and insulin resistance in men. Diabetes Care 2010;33:1618-24
34. Blouin K, Boivin A, Tchernof A. Androgens and body fat distribution. J Steroid Biochem Mol Biol 2008;108:272-80
35. Poirier P, Giles TD, Bray GA, et al. Obesity and cardiovascular disease: Pathophysiology, evaluation, and effect of weight loss. Arterioscler Thromb Vasc Biol 2006;26: 968-76
36. Saad F, Haider A, Doros G, Traish A. Long-term treatment of hypogonadal men with testosterone produces substantial and sustained weight loss. Obesity 2013;21:1975-81
37. Yassin AA, Doros G. Testosterone therapy in hypogonadal men results in sustained and clinically meaningful weight loss. Clin Obes 2013;3:73-83
38. Kapoor D, Jones TH. Smoking and hormones in health and endocrine disorders. Eur J Endocrinol 2005;152:491-9
39. English KM, Pugh P, Parry H, et al. Effect of cigarette smoking on levels of bioavailable testosterone in healthy men. Clin Sci 2001; 100:661-5